TY  - CONF

T1  - Bone metabolism biomarkers in men with advanced prostate cancer (PC) and bone metastases treated with denosumab versus zoledronic acid (ZA).

JO  - Journal of Clinical Oncology

PY  - 2015/03/01

AU  - Smith MR

AU  - Brown JE

AU  - Fizazi K

AU  - Klotz L

AU  - Marx GM

AU  - Wang H

AU  - Warner D

AU  - Lipton A

ED  - 

DO  - DOI: 10.1200/jco.2015.33.7_suppl.267

PB  - American Society of Clinical Oncology (ASCO)

VL  - 33

IS  - 7_suppl

SP  - 267

EP  - 267

Y2  - 2024/09/19

ER  -